Clinical trial
Antiangiogenic Effects of BCG on Urinary Concentration of Angiogenic Factors
NCT00216814 · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, Other · Terminated
Key facts
| NCT number | NCT00216814 |
|---|---|
| Title | Antiangiogenic Effects of BCG on Urinary Concentration of Angiogenic Factors |
| Official title | Intravesically Administered BCG May Have Antiangiogenic Effects on Urinary Concentrations of Basic Fibroblast Growth Factor ( bFGF), Vascular Endothelial Growth Factor (VEGF) and Interleukin (IL-8) |
| Lead sponsor | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, Other |
| Status | Terminated |
| Study type | Observational |
| Conditions | Bladder Cancer |
| Enrollment | 220 |
| Start date | Oct 1, 2003 |
| Completion | Sep 1, 2007 |
| First posted | Sep 22, 2005 |
| Last update posted | Apr 22, 2008 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: